Literature DB >> 13016243

Otitis in childhood; a clinical and sero-bacteriological study with special reference to the significance of Haemophilus influenzae in relapses.

G BJUGGREN, G TUNEVALL.   

Abstract

Entities:  

Keywords:  OTITIS MEDIA/in infant and child

Mesh：

Year:  1952        PMID： 13016243     DOI： 10.3109/00016485209120357

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN： 0001-6489            Impact factor:   1.494


× No keyword cloud information.
  6 in total

1.  Antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

2.  Haemophilus influenzae in otitis media and sinusitis: serotypes and susceptibilty to ampicillin and amoxycillin in vitro.

Authors:  A M Jokipii; L Jokipii
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas.

Authors:  X X Gu; J Sun; S Jin; S J Barenkamp; D J Lim; J B Robbins; J Battey
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Etiology of acute otitis media in infants and children.

Authors:  O E Laxdal; R M Blake; T Cartmill; H E Robertson
Journal:  Can Med Assoc J       Date:  1966-01-22       Impact factor: 8.262

5.  Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media.

Authors:  J L Sloyer; V M Howie; J H Ploussard; A J Ammann; R Austrian; R B Johnston
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

6.  Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas.

Authors:  S J Barenkamp
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.